About BugSpeaks
BugSpeaks is a company based in Bengaluru (India) founded in 2014 by Kumar Sankaran, Prabhath Kamati Manjappa, and Debojyoti Dhar. It operates as a D2C and B2B. The company has 17 employees as of March 31, 2017. BugSpeaks offers products and services including BugSpeaks Test and Probiotics and Synbiotics. BugSpeaks operates in a competitive market with competitors including Azitra, Seed, OptiBiotix Health, BiomeSense and Mybacs, among others.
- Headquarter Bengaluru, India
- Employees 17 as on 31 Mar, 2017
- Founders Kumar Sankaran, Prabhath Kamati Manjappa, Debojyoti Dhar
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Leucine Rich Bio Private Limited
- Date of Incorporation 21 Aug, 2014
- Jurisdiction Bangalore South, Karnataka, India
-
Annual Revenue
$108.3 K (USD)767.88as on Mar 31, 2017
-
Net Profit
$14.61 K (USD)134.7as on Mar 31, 2017
-
EBITDA
-$67.73 K (USD)-74.85as on Mar 31, 2017
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
17
as on Mar 31, 2017
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BugSpeaks
BugSpeaks offers a comprehensive portfolio of products and services, including BugSpeaks Test and Probiotics and Synbiotics.
Analyzes gut microbiome for personalized health and dietary recommendations.
Formulated supplements based on microbiome data for gut health improvement.
Funding Insights of BugSpeaks
Detailed funding history for BugSpeaks
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BugSpeaks
Investment portfolio details for BugSpeaks
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BugSpeaks
Detailed financials for BugSpeaks
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bugspeaks Comparisons
Peer comparison for BugSpeaks
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BugSpeaks
BugSpeaks operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Azitra, Seed, OptiBiotix Health, BiomeSense and Mybacs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Microbiome-based therapeutics for skin conditions like eczema are developed.
|
|
| Locked | Locked | Locked |
Synbiotics are developed for simulating the gut microbiome.
|
|
| Locked | Locked | Locked |
Microbial strains are developed for treating human metabolic diseases.
|
|
| Locked | Locked | Locked |
AI-enabled platform for microbiome data generation and analysis is developed.
|
|
| Locked | Locked | Locked |
Probiotic supplements for digestion are manufactured and marketed.
|
|
| Locked | Locked | Locked |
Microbiome-based therapeutics for nervous system disorders are developed.
|
Detailed competitors of BugSpeaks
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bugspeaks
Complete news archive for BugSpeaks
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BugSpeaks
BugSpeaks was founded in 2014.
BugSpeaks is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Kumar Sankaran is the current CEO of BugSpeaks. They have also founded this company.
As of Mar 31, 2017, the latest employee count at BugSpeaks is 17.
Annual revenue of BugSpeaks is $108.3K as on Mar 31, 2017.
Leucine Rich Bio , Based In Bangalore, India, Focuses On Gut Microbiome Testing Through The Bugspeaks Platform. They Collect And Analyze Stool Samples To Deliver Reports With Tailored Recommendations For Prebiotics, Probiotics, And Food To Enhance Immunity, Digestion, And Manage Conditions Like Diabetes. The Company Serves Individuals And Partners With Clinics, Emphasizing Transparency And Accuracy In Health Insights.
BugSpeaks's top competitors include Azitra, Seed and OptiBiotix Health.
BugSpeaks offers BugSpeaks Test and Probiotics and Synbiotics.